Talpain Tablets (Talnifluyamate)

Adult dose

Administer 370 mg of talniflumate per dose orally 3 times daily. For severe cases, administer 740 mg per dose. The dose may be adjusted appropriately according to age and symptoms.

This medication may increase the risk of gastrointestinal bleeding in individuals who regularly consume more than three alcoholic beverages a day; therefore, it is essential to consult a doctor or pharmacist. This medication may affect the cardiovascular system and increase the risk of serious thrombotic reactions such as myocardial infarction or stroke, so patients with cardiovascular diseases or risk factors should be especially cautious. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, and the risk may be higher for the elderly or those taking it for long periods. Individuals with a history of peptic ulcers or hypersensitivity to this medication or its components, those with allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs, patients with severe liver, kidney, or heart impairment, pregnant or breastfeeding women, and individuals with certain genetic metabolic disorders should not take this medication. Patients with mild to moderate liver, kidney, or heart impairment, those taking diuretics, the elderly, and those allergic to specific pigment components should take this medication with caution. This medication can cause various side effects, including hypersensitivity reactions, gastrointestinal issues, cardiovascular symptoms, skin rashes, central nervous system symptoms, and kidney damage, so any unusual symptoms should be discussed with a healthcare provider immediately. This medication should be used at the minimum effective dose for the shortest duration possible, and regular blood tests and liver and kidney function tests are necessary for long-term use. It is advisable to avoid concomitant use with other anti-inflammatory painkillers, and there may be drug interactions, so it is essential to inform about any other medications being taken. During pregnancy, especially in late stages, it may pose risks to the fetus, and breastfeeding women should consult a specialist before taking it as the drug may pass into breast milk. It should not be administered to children, particularly those under 12 years old, and the elderly should take the minimum effective dose with caution and be vigilant for side effects. This medication should be stored out of reach of children and should not be transferred to other containers.

nausea, vomiting, photosensitivity, asthma attacks, systemic weakness due to hypotension, hypersensitivity shock, diarrhea, abdominal bloating, constipation, indigestion, ulcerative stomatitis, abdominal pain, hematemesis, colitis, exacerbation of Crohn's disease, gastrointestinal bleeding, peptic ulcer, perforation, increased blood pressure, tachycardia, chest pain, arrhythmia, palpitations, hypotension, congestive heart failure, edema, hypertension, heart failure, vesicular reaction, Stevens-Johnson syndrome, Lyell syndrome, rash, urticaria, itching, purpura, infectious complications in skin and soft tissue affected by chickenpox, dizziness, acute renal failure, interstitial nephritis, nephrotic syndrome, fluorosis, abnormal liver function tests, thrombocytopenia

This medication should be stored in a tightly closed container to avoid exposure to air, and it is advisable to keep it in a cool, dry place away from direct sunlight. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance

Yellow round film-coated tablets

Package unit

(For domestic use) 500 tablets/bottle, 30 tablets/bottle (For export) 60 tablets (10 tablets/PTP x 6)